152 related articles for article (PubMed ID: 8406591)
21. Role of humoral factors in host resistance to the Bacteroides fragilis group.
Bjornson AB
Rev Infect Dis; 1990; 12 Suppl 2():S161-8. PubMed ID: 2406868
[TBL] [Abstract][Full Text] [Related]
22. Interaction of Neisseria gonorrhoeae with classical complement components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigen.
Schweinle JE; Hitchcock PJ; Tenner AJ; Hammer CH; Frank MM; Joiner KA
J Clin Invest; 1989 Feb; 83(2):397-403. PubMed ID: 2492308
[TBL] [Abstract][Full Text] [Related]
23. Anti-complement effects of lactoferrin-derived peptides.
Samuelsen Ø; Haukland HH; Ulvatne H; Vorland LH
FEMS Immunol Med Microbiol; 2004 Jun; 41(2):141-8. PubMed ID: 15145458
[TBL] [Abstract][Full Text] [Related]
24. Adiponectin binds C1q and activates the classical pathway of complement.
Peake PW; Shen Y; Walther A; Charlesworth JA
Biochem Biophys Res Commun; 2008 Mar; 367(3):560-5. PubMed ID: 18179772
[TBL] [Abstract][Full Text] [Related]
25. Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis.
Jacks-Weis J; Kim Y; Cleary PP
J Immunol; 1982 Apr; 128(4):1897-902. PubMed ID: 7037956
[TBL] [Abstract][Full Text] [Related]
26. Binding ability of complement receptor CR1 to C3 bound on the surface of M+ group A streptococci.
Hong K; Harada T; Nishimura T; Inoue K
Immunology; 1993 Dec; 80(4):640-4. PubMed ID: 8307615
[TBL] [Abstract][Full Text] [Related]
27. High dose intravenous immunoglobulin does not affect complement-bacteria interactions.
Wagner E; Platt JL; Frank MM
J Immunol; 1998 Feb; 160(4):1936-43. PubMed ID: 9469456
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of complement activation by a secreted Staphylococcus aureus protein.
Lee LY; Höök M; Haviland D; Wetsel RA; Yonter EO; Syribeys P; Vernachio J; Brown EL
J Infect Dis; 2004 Aug; 190(3):571-9. PubMed ID: 15243934
[TBL] [Abstract][Full Text] [Related]
29. Activation of classical pathway of complement cascade by soluble oligomers of prion.
Dumestre-Pérard C; Osmundson J; Lemaire-Vieille C; Thielens N; Grives A; Favier B; Csopaki F; Jamin M; Gagnon J; Cesbron JY
Cell Microbiol; 2007 Dec; 9(12):2870-9. PubMed ID: 17991046
[TBL] [Abstract][Full Text] [Related]
30. A role for C-reactive protein in the complement-mediated stimulation of human neutrophils by type 27 Streptococcus pneumoniae.
Edwards KM; Gewurz H; Lint TF; Mold C
J Immunol; 1982 Jun; 128(6):2493-6. PubMed ID: 7077077
[TBL] [Abstract][Full Text] [Related]
31. Role of complement in Mycobacterium avium pathogenesis: in vivo and in vitro analyses of the host response to infection in the absence of complement component C3.
Bohlson SS; Strasser JA; Bower JJ; Schorey JS
Infect Immun; 2001 Dec; 69(12):7729-35. PubMed ID: 11705954
[TBL] [Abstract][Full Text] [Related]
32. The Group B Streptococcus-Secreted Protein CIP Interacts with C4, Preventing C3b Deposition via the Lectin and Classical Complement Pathways.
Pietrocola G; Rindi S; Rosini R; Buccato S; Speziale P; Margarit I
J Immunol; 2016 Jan; 196(1):385-94. PubMed ID: 26608922
[TBL] [Abstract][Full Text] [Related]
33. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
Wouters D; Brouwer MC; Daha MR; Hack CE
Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
[TBL] [Abstract][Full Text] [Related]
34. Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis.
Zhang MX; Klein B
Infect Immun; 1997 May; 65(5):1849-55. PubMed ID: 9125571
[TBL] [Abstract][Full Text] [Related]
35. Antibodies directed against O-acetylated sialoglycoconjugates accelerate complement activation in Leishmania donovani promastigotes.
Bandyopadhyay S; Chatterjee M; Das T; Bandyopadhyay S; Sundar S; Mandal C
J Infect Dis; 2004 Dec; 190(11):2010-9. PubMed ID: 15529267
[TBL] [Abstract][Full Text] [Related]
36. Activation of the classical complement pathway by Bacillus anthracis is the primary mechanism for spore phagocytosis and involves the spore surface protein BclA.
Gu C; Jenkins SA; Xue Q; Xu Y
J Immunol; 2012 May; 188(9):4421-31. PubMed ID: 22442442
[TBL] [Abstract][Full Text] [Related]
37. Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein.
Carlsson F; Berggård K; Stålhammar-Carlemalm M; Lindahl G
J Exp Med; 2003 Oct; 198(7):1057-68. PubMed ID: 14517274
[TBL] [Abstract][Full Text] [Related]
38. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q.
Kang YS; Do Y; Lee HK; Park SH; Cheong C; Lynch RM; Loeffler JM; Steinman RM; Park CG
Cell; 2006 Apr; 125(1):47-58. PubMed ID: 16615889
[TBL] [Abstract][Full Text] [Related]
39. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice.
Brown JS; Hussell T; Gilliland SM; Holden DW; Paton JC; Ehrenstein MR; Walport MJ; Botto M
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16969-74. PubMed ID: 12477926
[TBL] [Abstract][Full Text] [Related]
40. Deficient classical complement pathway activity in newborn sera.
Edwards MS; Buffone GJ; Fuselier PA; Weeks JL; Baker CJ
Pediatr Res; 1983 Aug; 17(8):685-8. PubMed ID: 6412204
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
